P-978 Geftinib (ZD 1839, Iressa®) in treatment of advanced non-small cell lung cancers — one institutional experience on an expanded access program

Autor:	Hana Honova, P. Mares, J. Dvorak, V. Tomancova, Milada Zemanova, Martin Safanda, Lubos Petruzelka
Rok vydání:	2005
Předmět:	Pulmonary and Respiratory Medicine Oncology Cancer Research medicine.medical_specialty Lung medicine.anatomical_structure business.industry Expanded access Internal medicine medicine Non small cell business
Zdroj:	Lung Cancer. 49:S377
ISSN:	0169-5002
DOI:	10.1016/s0169-5002(05)81471-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7958cc3491f684f4c14e6d9ad78df4bd https://doi.org/10.1016/s0169-5002(05)81471-0 Zobrazit plný text záznamu Full Text from ScienceDirect